Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Osteosarcoma
Hannah C. Beird, Stefan Bielack, Adrienne M. Flanagan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 279

Showing 1-25 of 279 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 79
Advances in Osteosarcoma
Isidora Panez-Toro, Javier Muñoz-García, Jorge William Vargas-Franco, et al.
Current Osteoporosis Reports (2023) Vol. 21, Iss. 4, pp. 330-343
Open Access | Times Cited: 66
Advances on immunotherapy for osteosarcoma
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Biomedical applications of NIR-II organic small molecule fluorescent probes in different organs
Lizhen Xu, Qian Zhang, Xin Wang, et al.
Coordination Chemistry Reviews (2024) Vol. 519, pp. 216122-216122
Closed Access | Times Cited: 15
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Alendronate Triggered Dual‐Cascade Targeting Prodrug Nanoparticles for Enhanced Tumor Penetration and STING Activation of Osteosarcoma
Meifang Shen, Yushu Wang, Tiejun Bing, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 49
Open Access | Times Cited: 35
Traumatic muscle injury
Pascal Édouard, Gustaaf Reurink, Abigail L. Mackey, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 27
A multifunctional nano-hydroxyapatite/MXene scaffold for the photothermal/dynamic treatment of bone tumours and simultaneous tissue regeneration
Guannan Zhang, Ying Lu, Jianbo Song, et al.
Journal of Colloid and Interface Science (2023) Vol. 652, pp. 1673-1684
Closed Access | Times Cited: 25
Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells
Wenkai Chen, Zongguang Li, Naichun Yu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Artificial intelligence-based radiomics in bone tumors: Technical advances and clinical application
Yichen Meng, Yue Yang, Miao Hu, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 75-87
Closed Access | Times Cited: 22
A Se Nanoparticle/MgFe‐LDH Composite Nanosheet as a Multifunctional Platform for Osteosarcoma Eradication, Antibacterial and Bone Reconstruction
Yixin Bian, Kexin Zhao, Tingting Hu, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 12
Soy isoflavones induces mitophagy to inhibit the progression of osteosarcoma by blocking the AKT/mTOR signaling pathway
Ziang Zheng, Xinghan Zhao, Bo Yuan, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 10
3D-Printed Magnesium Peroxide-Incorporated Scaffolds with Sustained Oxygen Release and Enhanced Photothermal Performance for Osteosarcoma Multimodal Treatments
Xu Haixia, Ziyue Peng, Lin Jiezhao, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 8, pp. 9626-9639
Closed Access | Times Cited: 8
Global, regional, and national burden of malignant neoplasm of bone and articular cartilage in adults aged 65 years and older, 1990–2021: a systematic analysis based on the global burden of disease study 2021
Xiang Zhang, Yuxing Dai, Yuelin Chen, et al.
Aging Clinical and Experimental Research (2025) Vol. 37, Iss. 1
Open Access | Times Cited: 1
Advances in Radionuclide-Labeled Biological Carriers for Tumor Imaging and Treatment
Yaozhang Yang, Jing Wang, Yan Zhong, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access | Times Cited: 1
Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution
Jose Espejo Valle-Inclán, Solange De Noon, Katherine Trevers, et al.
Cell (2025)
Open Access | Times Cited: 1
Eriodictyol-cisplatin coated nanomedicine synergistically promote osteosarcoma cells ferroptosis and chemosensitivity
Zili Lin, Yusheng Li, Ziyi Wu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Image segmentation technology based on transformer in medical decision‐making system
Keke He, Fangfang Gou, Jia Wu
IET Image Processing (2023) Vol. 17, Iss. 10, pp. 3040-3054
Open Access | Times Cited: 21
Black phosphorus quantum dots camouflaged with platelet-osteosarcoma hybrid membrane and doxorubicin for combined therapy of osteosarcoma
Yanlong Xu, Longhai Du, Binxu Han, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Cancer-Erythrocyte Membrane-Mimicking Fe3O4 Nanoparticles and DHJS for Ferroptosis/Immunotherapy Synergism in Tumors
Kaixu Yu, Ying Chen, Lu Zhang, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 38, pp. 44689-44710
Closed Access | Times Cited: 21
Time‐Sequential and Multi‐Functional 3D Printed MgO2/PLGA Scaffold Developed as a Novel Biodegradable and Bioactive Bone Substitute for Challenging Postsurgical Osteosarcoma Treatment
Cairong Li, Wei Zhang, Yangyi Nie, et al.
Advanced Materials (2023) Vol. 36, Iss. 34
Closed Access | Times Cited: 21
Alendronate PtIV Prodrug Amphiphile for Enhanced Chemotherapy Targeting and Bone Destruction Inhibition in Osteosarcoma
Kaichuang Sun, Lu Yuan, Chen Shen, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 7
Closed Access | Times Cited: 17
Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo
Yang Kong, Xiangrong Li, Huanle Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Bionic Bilayer Scaffold for Synchronous Hyperthermia Therapy of Orthotopic Osteosarcoma and Osteochondral Regeneration
Chenchi Gong, Jun Wang, Faqiang Tang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 7, pp. 8538-8553
Closed Access | Times Cited: 6
Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index
Yongjie Wang, Xiaolong Ma, Enjie Xu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top